# Evidence of Haloperidol Absorption After Topical Administration

> **NCT01684969** · EARLY_PHASE1 · WITHDRAWN · sponsor: **Eric E. Prommer**

## Conditions studied

- Nausea
- Vomiting

## Interventions

- **DRUG:** Haloperidol
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT01684969
- **Lead sponsor:** Eric E. Prommer
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2012-03
- **Primary completion:** 2013-05
- **Final completion:** 2013-05
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** lack of accrual and funding is about to expire.
- **Last updated:** 2016-03-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01684969

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01684969, "Evidence of Haloperidol Absorption After Topical Administration". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT01684969. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*